Abivax announces presentation of four abstracts for obefazim

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Evanston , Illinois , United States , Northwestern University , Washington , Paris , France General , France , Burrillb Crohn , Parambirs Dulai , Didier Scherrer , Enregistrement Universel , Brucee Sands , Sheldon Sloan , Patrick Malloy , Twitter , Gi Cancer Research Models , Abivax Communications , Henryd Janowitz Division Of Gastroenterology , Linkedin , Exchange Commission On , Icahn School Of Medicine At Mount Sinai , Division Of Gastroenterology , Digestive Disease Week , Euronext Paris , Chief Medical Officer , Icahn School , Mount Sinai , Molecular Biology , Scientific Officer , Research Models , Engineered Cell , Tissue Platforms , Controlled Clinical Trials , Product Theater , Investigational New , Can Stabilize , Inflammatory Response , Ulcerative Colitis , Associate Professor , Although Abivax , French Autorit , Des March , Annual Report , Exchange Commission ,